ZE
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
9.51
Exchange
XCSE - Nasdaq Copenhagen A/S
-18 %
Last period ROE
-66%
ROE has decreased in 5 years
What is ROE ?
The return on equity ratio shows how much net profit a company earns per unit of equity. To calculate the company's rating, the return on equity adjusted for the average level of financial leverage for 3 years is taken into account. The value of 20% is the benchmark for Eyestock Rating calculation.
See also Zealand Pharma
Company Analysis
ZEAL.CO valuation, rating, competitors, insights and company profile
Eyestock Rating
ZEAL.CO financial analysis by Eyestock methodology
Valuation
ZEAL.CO valuation using historical relative method
Statements
ZEAL.CO Income Statements, Balance Sheet and Cash Flow Statements
Dividends
ZEAL.CO dividend yield and annual dividend
The return on equity ratio shows how much net profit a company earns per unit of equity. To calculate the company's rating, the return on equity adjusted for the average level of financial leverage for 3 years is taken into account. The value of 20% is the benchmark for Eyestock Rating calculation.
Zealand Pharma`s ROE for the last twelve months ended 2024-06-30 is -18 %
